Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Diabetic Eye Disease Devices Market by Devices (Surgery, Ophthalmic Diagnostic Monitoring Equipment, Vision Care), by Diseases (Diabetic Retinopathy, Diabetic Macular Edema (DME), Cataract, Glaucoma, Others) and by End-User (Hospitals, Ophthalmic Clinics, OthersOthersOthersOthersOthers): Global Opportunity Analysis and Industry Forecast, 2023-2032

A03647

Pages: NA

Charts: NA

Tables: NA

Diabetic eye disease devices are medical devices used to treat and diagnose renal complications that occur due to diabetes. The most common diabetic eye diseases include diabetic retinopathy, diabetic macular edema, cataract, and glaucoma. These conditions may lead to complete blindness if not treated on time.

The growing prevalence of diabetic eye diseases owning to increasing smoking addiction, eye injury, hormone replacement therapy, and diseases such as diabetes, hypertension, and obesity drive the diabetic eye disease devices market growth. In addition, increasing geriatric population who suffer from diabetic eye diseases increases the market growth.

There is an increasing demand for diabetic eye diseases devices to avoid visual impairment and loss of vision. However, dearth of skilled professionals with expertise in ophthalmic surgery, lack of healthcare infrastructure in developing countries, low awareness of eye surgery, and stringent government regulations associated with the safety & efficacy of medical devices hamper the market growth. Ongoing R&D activities related to diabetic eye disease devices are anticipated to present new opportunities for the market.

The market is segmented on the basis of devices, diseases, end-users, and region. Based on devices, the market is divided into surgery, ophthalmic diagnostic & monitoring equipment, and vision care. Based on diseases the market is categorized into diabetic retinopathy, diabetic macular edema (DME), cataract, glaucoma, and others. Based on end-users the market is segmented into hospitals, ophthalmic clinics, and others. Based on region, the global diabetic eye disease devices market is segmented into North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits:

  • The study provides an in-depth analysis of the global diabetic eye disease devices market, with current trends and future estimations to elucidate investment pockets.
  • Comprehensive analysis of factors that drive and restrict the growth of the market has been provided.
  • The report provides a quantitative analysis to help stakeholders capitalize on prevailing market opportunities in terms of value.
  • Extensive analysis of different segments helps understand various products of the market.
  • Key players have been profiled and their strategies thoroughly analyzed, which predict the competitive outlook of the market.

 Key Market Segments

  • By Devices
    • Surgery
    • Ophthalmic Diagnostic & Monitoring Equipment
    • Vision Care
  • By Diseases
    • Diabetic Retinopathy
    • Diabetic Macular Edema (DME)
    • Cataract
    • Glaucoma
    • Others
  • By End-User
    • Hospitals
    • Ophthalmic Clinics
    • OthersOthersOthersOthersOthers
  • By Region
    • North America
    • Europe
    • Asia-Pacific
    • LAMEA

 
Key Market Players

  • STAAR Surgical Company
  • Essilor International S.A.
  • Nidek Co., Ltd.
  • Actavis plc
  • Aaren Scientific Inc.
  • Valeant Pharmaceuticals International, Inc.
  • CooperVision AG
  • Alcon Inc.
  • Johnson & Johnson
  • Novartis AG

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: DIABETIC EYE DISEASE DEVICES MARKET, BY DEVICES

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Devices

    • 4.2. Surgery

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Ophthalmic Diagnostic And Monitoring Equipment

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Vision Care

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: DIABETIC EYE DISEASE DEVICES MARKET, BY DISEASES

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Diseases

    • 5.2. Diabetic Retinopathy

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Diabetic Macular Edema (DME)

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Cataract

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Glaucoma

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Others

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

  • CHAPTER 6: DIABETIC EYE DISEASE DEVICES MARKET, BY END-USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End-user

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Ophthalmic Clinics

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. OthersOthersOthersOthersOthers

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: DIABETIC EYE DISEASE DEVICES MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Devices

      • 7.2.3. Market Size and Forecast, By Diseases

      • 7.2.4. Market Size and Forecast, By End-user

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Diabetic Eye Disease Devices Market

        • 7.2.6.1. Market Size and Forecast, By Devices
        • 7.2.6.2. Market Size and Forecast, By Diseases
        • 7.2.6.3. Market Size and Forecast, By End-user

      • 7.2.7. Canada Diabetic Eye Disease Devices Market

        • 7.2.7.1. Market Size and Forecast, By Devices
        • 7.2.7.2. Market Size and Forecast, By Diseases
        • 7.2.7.3. Market Size and Forecast, By End-user

      • 7.2.8. Mexico Diabetic Eye Disease Devices Market

        • 7.2.8.1. Market Size and Forecast, By Devices
        • 7.2.8.2. Market Size and Forecast, By Diseases
        • 7.2.8.3. Market Size and Forecast, By End-user

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Devices

      • 7.3.3. Market Size and Forecast, By Diseases

      • 7.3.4. Market Size and Forecast, By End-user

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Diabetic Eye Disease Devices Market

        • 7.3.6.1. Market Size and Forecast, By Devices
        • 7.3.6.2. Market Size and Forecast, By Diseases
        • 7.3.6.3. Market Size and Forecast, By End-user

      • 7.3.7. Germany Diabetic Eye Disease Devices Market

        • 7.3.7.1. Market Size and Forecast, By Devices
        • 7.3.7.2. Market Size and Forecast, By Diseases
        • 7.3.7.3. Market Size and Forecast, By End-user

      • 7.3.8. Italy Diabetic Eye Disease Devices Market

        • 7.3.8.1. Market Size and Forecast, By Devices
        • 7.3.8.2. Market Size and Forecast, By Diseases
        • 7.3.8.3. Market Size and Forecast, By End-user

      • 7.3.9. Spain Diabetic Eye Disease Devices Market

        • 7.3.9.1. Market Size and Forecast, By Devices
        • 7.3.9.2. Market Size and Forecast, By Diseases
        • 7.3.9.3. Market Size and Forecast, By End-user

      • 7.3.10. UK Diabetic Eye Disease Devices Market

        • 7.3.10.1. Market Size and Forecast, By Devices
        • 7.3.10.2. Market Size and Forecast, By Diseases
        • 7.3.10.3. Market Size and Forecast, By End-user

      • 7.3.11. Russia Diabetic Eye Disease Devices Market

        • 7.3.11.1. Market Size and Forecast, By Devices
        • 7.3.11.2. Market Size and Forecast, By Diseases
        • 7.3.11.3. Market Size and Forecast, By End-user

      • 7.3.12. Rest Of Europe Diabetic Eye Disease Devices Market

        • 7.3.12.1. Market Size and Forecast, By Devices
        • 7.3.12.2. Market Size and Forecast, By Diseases
        • 7.3.12.3. Market Size and Forecast, By End-user

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Devices

      • 7.4.3. Market Size and Forecast, By Diseases

      • 7.4.4. Market Size and Forecast, By End-user

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Diabetic Eye Disease Devices Market

        • 7.4.6.1. Market Size and Forecast, By Devices
        • 7.4.6.2. Market Size and Forecast, By Diseases
        • 7.4.6.3. Market Size and Forecast, By End-user

      • 7.4.7. Japan Diabetic Eye Disease Devices Market

        • 7.4.7.1. Market Size and Forecast, By Devices
        • 7.4.7.2. Market Size and Forecast, By Diseases
        • 7.4.7.3. Market Size and Forecast, By End-user

      • 7.4.8. India Diabetic Eye Disease Devices Market

        • 7.4.8.1. Market Size and Forecast, By Devices
        • 7.4.8.2. Market Size and Forecast, By Diseases
        • 7.4.8.3. Market Size and Forecast, By End-user

      • 7.4.9. South Korea Diabetic Eye Disease Devices Market

        • 7.4.9.1. Market Size and Forecast, By Devices
        • 7.4.9.2. Market Size and Forecast, By Diseases
        • 7.4.9.3. Market Size and Forecast, By End-user

      • 7.4.10. Australia Diabetic Eye Disease Devices Market

        • 7.4.10.1. Market Size and Forecast, By Devices
        • 7.4.10.2. Market Size and Forecast, By Diseases
        • 7.4.10.3. Market Size and Forecast, By End-user

      • 7.4.11. Thailand Diabetic Eye Disease Devices Market

        • 7.4.11.1. Market Size and Forecast, By Devices
        • 7.4.11.2. Market Size and Forecast, By Diseases
        • 7.4.11.3. Market Size and Forecast, By End-user

      • 7.4.12. Malaysia Diabetic Eye Disease Devices Market

        • 7.4.12.1. Market Size and Forecast, By Devices
        • 7.4.12.2. Market Size and Forecast, By Diseases
        • 7.4.12.3. Market Size and Forecast, By End-user

      • 7.4.13. Indonesia Diabetic Eye Disease Devices Market

        • 7.4.13.1. Market Size and Forecast, By Devices
        • 7.4.13.2. Market Size and Forecast, By Diseases
        • 7.4.13.3. Market Size and Forecast, By End-user

      • 7.4.14. Rest of Asia Pacific Diabetic Eye Disease Devices Market

        • 7.4.14.1. Market Size and Forecast, By Devices
        • 7.4.14.2. Market Size and Forecast, By Diseases
        • 7.4.14.3. Market Size and Forecast, By End-user

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Devices

      • 7.5.3. Market Size and Forecast, By Diseases

      • 7.5.4. Market Size and Forecast, By End-user

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Diabetic Eye Disease Devices Market

        • 7.5.6.1. Market Size and Forecast, By Devices
        • 7.5.6.2. Market Size and Forecast, By Diseases
        • 7.5.6.3. Market Size and Forecast, By End-user

      • 7.5.7. South Africa Diabetic Eye Disease Devices Market

        • 7.5.7.1. Market Size and Forecast, By Devices
        • 7.5.7.2. Market Size and Forecast, By Diseases
        • 7.5.7.3. Market Size and Forecast, By End-user

      • 7.5.8. Saudi Arabia Diabetic Eye Disease Devices Market

        • 7.5.8.1. Market Size and Forecast, By Devices
        • 7.5.8.2. Market Size and Forecast, By Diseases
        • 7.5.8.3. Market Size and Forecast, By End-user

      • 7.5.9. UAE Diabetic Eye Disease Devices Market

        • 7.5.9.1. Market Size and Forecast, By Devices
        • 7.5.9.2. Market Size and Forecast, By Diseases
        • 7.5.9.3. Market Size and Forecast, By End-user

      • 7.5.10. Argentina Diabetic Eye Disease Devices Market

        • 7.5.10.1. Market Size and Forecast, By Devices
        • 7.5.10.2. Market Size and Forecast, By Diseases
        • 7.5.10.3. Market Size and Forecast, By End-user

      • 7.5.11. Rest of LAMEA Diabetic Eye Disease Devices Market

        • 7.5.11.1. Market Size and Forecast, By Devices
        • 7.5.11.2. Market Size and Forecast, By Diseases
        • 7.5.11.3. Market Size and Forecast, By End-user

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Novartis AG

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Johnson And Johnson

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Aaren Scientific Inc.

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Valeant Pharmaceuticals International, Inc.

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Essilor International S.A.

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Alcon Inc.

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Nidek Co., Ltd.

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. STAAR Surgical Company

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Actavis Plc

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. CooperVision AG

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET FOR SURGERY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET FOR OPHTHALMIC DIAGNOSTIC AND MONITORING EQUIPMENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET FOR VISION CARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET FOR DIABETIC RETINOPATHY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET FOR DIABETIC MACULAR EDEMA (DME), BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET FOR CATARACT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET FOR GLAUCOMA, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET FOR OPHTHALMIC CLINICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET FOR OTHERSOTHERSOTHERSOTHERSOTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA DIABETIC EYE DISEASE DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 20. U.S. DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 21. U.S. DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 22. U.S. DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 23. CANADA DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 24. CANADA DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 25. CANADA DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 26. MEXICO DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 27. MEXICO DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 28. MEXICO DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 29. EUROPE DIABETIC EYE DISEASE DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 30. EUROPE DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 31. EUROPE DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 32. EUROPE DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 33. FRANCE DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 34. FRANCE DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 35. FRANCE DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 36. GERMANY DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 37. GERMANY DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 38. GERMANY DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 39. ITALY DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 40. ITALY DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 41. ITALY DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 42. SPAIN DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 43. SPAIN DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 44. SPAIN DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 45. UK DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 46. UK DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 47. UK DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 48. RUSSIA DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 49. RUSSIA DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 50. RUSSIA DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 51. REST OF EUROPE DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 52. REST OF EUROPE DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 53. REST OF EUROPE DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 54. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 55. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 56. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 57. ASIA-PACIFIC DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 58. CHINA DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 59. CHINA DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 60. CHINA DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 61. JAPAN DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 62. JAPAN DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 63. JAPAN DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 64. INDIA DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 65. INDIA DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 66. INDIA DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 67. SOUTH KOREA DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 68. SOUTH KOREA DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 69. SOUTH KOREA DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 70. AUSTRALIA DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 71. AUSTRALIA DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 72. AUSTRALIA DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 73. THAILAND DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 74. THAILAND DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 75. THAILAND DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 76. MALAYSIA DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 77. MALAYSIA DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 78. MALAYSIA DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 79. INDONESIA DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 80. INDONESIA DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 81. INDONESIA DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 82. REST OF ASIA PACIFIC DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 85. LAMEA DIABETIC EYE DISEASE DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 86. LAMEA DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 87. LAMEA DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 88. LAMEA DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 89. BRAZIL DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 90. BRAZIL DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 91. BRAZIL DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 92. SOUTH AFRICA DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 93. SOUTH AFRICA DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 94. SOUTH AFRICA DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 95. SAUDI ARABIA DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 96. SAUDI ARABIA DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 97. SAUDI ARABIA DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 98. UAE DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 99. UAE DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 100. UAE DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 101. ARGENTINA DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 102. ARGENTINA DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 103. ARGENTINA DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 104. REST OF LAMEA DIABETIC EYE DISEASE DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 105. REST OF LAMEA DIABETIC EYE DISEASE DEVICES, BY DISEASES, 2025-2033 ($MILLION)
  • TABLE 106. REST OF LAMEA DIABETIC EYE DISEASE DEVICES, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 107. NOVARTIS AG: KEY EXECUTIVES
  • TABLE 108. NOVARTIS AG: COMPANY SNAPSHOT
  • TABLE 109. NOVARTIS AG: OPERATING SEGMENTS
  • TABLE 110. NOVARTIS AG: PRODUCT PORTFOLIO
  • TABLE 111. NOVARTIS AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. JOHNSON AND JOHNSON: KEY EXECUTIVES
  • TABLE 113. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
  • TABLE 114. JOHNSON AND JOHNSON: OPERATING SEGMENTS
  • TABLE 115. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
  • TABLE 116. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. AAREN SCIENTIFIC INC.: KEY EXECUTIVES
  • TABLE 118. AAREN SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 119. AAREN SCIENTIFIC INC.: OPERATING SEGMENTS
  • TABLE 120. AAREN SCIENTIFIC INC.: PRODUCT PORTFOLIO
  • TABLE 121. AAREN SCIENTIFIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 122. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.: KEY EXECUTIVES
  • TABLE 123. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.: COMPANY SNAPSHOT
  • TABLE 124. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.: OPERATING SEGMENTS
  • TABLE 125. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.: PRODUCT PORTFOLIO
  • TABLE 126. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 127. ESSILOR INTERNATIONAL S.A.: KEY EXECUTIVES
  • TABLE 128. ESSILOR INTERNATIONAL S.A.: COMPANY SNAPSHOT
  • TABLE 129. ESSILOR INTERNATIONAL S.A.: OPERATING SEGMENTS
  • TABLE 130. ESSILOR INTERNATIONAL S.A.: PRODUCT PORTFOLIO
  • TABLE 131. ESSILOR INTERNATIONAL S.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 132. ALCON INC.: KEY EXECUTIVES
  • TABLE 133. ALCON INC.: COMPANY SNAPSHOT
  • TABLE 134. ALCON INC.: OPERATING SEGMENTS
  • TABLE 135. ALCON INC.: PRODUCT PORTFOLIO
  • TABLE 136. ALCON INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 137. NIDEK CO., LTD.: KEY EXECUTIVES
  • TABLE 138. NIDEK CO., LTD.: COMPANY SNAPSHOT
  • TABLE 139. NIDEK CO., LTD.: OPERATING SEGMENTS
  • TABLE 140. NIDEK CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 141. NIDEK CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142. STAAR SURGICAL COMPANY: KEY EXECUTIVES
  • TABLE 143. STAAR SURGICAL COMPANY: COMPANY SNAPSHOT
  • TABLE 144. STAAR SURGICAL COMPANY: OPERATING SEGMENTS
  • TABLE 145. STAAR SURGICAL COMPANY: PRODUCT PORTFOLIO
  • TABLE 146. STAAR SURGICAL COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. ACTAVIS PLC: KEY EXECUTIVES
  • TABLE 148. ACTAVIS PLC: COMPANY SNAPSHOT
  • TABLE 149. ACTAVIS PLC: OPERATING SEGMENTS
  • TABLE 150. ACTAVIS PLC: PRODUCT PORTFOLIO
  • TABLE 151. ACTAVIS PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152. COOPERVISION AG: KEY EXECUTIVES
  • TABLE 153. COOPERVISION AG: COMPANY SNAPSHOT
  • TABLE 154. COOPERVISION AG: OPERATING SEGMENTS
  • TABLE 155. COOPERVISION AG: PRODUCT PORTFOLIO
  • TABLE 156. COOPERVISION AG: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL DIABETIC EYE DISEASE DEVICES MARKET
  • FIGURE 3. SEGMENTATION DIABETIC EYE DISEASE DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN DIABETIC EYE DISEASE DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALDIABETIC EYE DISEASE DEVICES MARKET
  • FIGURE 11. DIABETIC EYE DISEASE DEVICES MARKET SEGMENTATION, BY BY DEVICES
  • FIGURE 12. DIABETIC EYE DISEASE DEVICES MARKET FOR SURGERY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. DIABETIC EYE DISEASE DEVICES MARKET FOR OPHTHALMIC DIAGNOSTIC AND MONITORING EQUIPMENT, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. DIABETIC EYE DISEASE DEVICES MARKET FOR VISION CARE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. DIABETIC EYE DISEASE DEVICES MARKET SEGMENTATION, BY BY DISEASES
  • FIGURE 16. DIABETIC EYE DISEASE DEVICES MARKET FOR DIABETIC RETINOPATHY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. DIABETIC EYE DISEASE DEVICES MARKET FOR DIABETIC MACULAR EDEMA (DME), BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. DIABETIC EYE DISEASE DEVICES MARKET FOR CATARACT, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. DIABETIC EYE DISEASE DEVICES MARKET FOR GLAUCOMA, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. DIABETIC EYE DISEASE DEVICES MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. DIABETIC EYE DISEASE DEVICES MARKET SEGMENTATION, BY BY END-USER
  • FIGURE 22. DIABETIC EYE DISEASE DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. DIABETIC EYE DISEASE DEVICES MARKET FOR OPHTHALMIC CLINICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. DIABETIC EYE DISEASE DEVICES MARKET FOR OTHERSOTHERSOTHERSOTHERSOTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 26. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 27. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 28. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 29. COMPETITIVE DASHBOARD
  • FIGURE 30. COMPETITIVE HEATMAP: DIABETIC EYE DISEASE DEVICES MARKET
  • FIGURE 31. TOP PLAYER POSITIONING, 2024
  • FIGURE 32. NOVARTIS AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 33. NOVARTIS AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 34. NOVARTIS AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 35. JOHNSON AND JOHNSON: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 36. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 37. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 38. AAREN SCIENTIFIC INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 39. AAREN SCIENTIFIC INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 40. AAREN SCIENTIFIC INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 41. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 42. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 43. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 44. ESSILOR INTERNATIONAL S.A.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 45. ESSILOR INTERNATIONAL S.A.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 46. ESSILOR INTERNATIONAL S.A.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 47. ALCON INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 48. ALCON INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 49. ALCON INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 50. NIDEK CO., LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 51. NIDEK CO., LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 52. NIDEK CO., LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 53. STAAR SURGICAL COMPANY: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 54. STAAR SURGICAL COMPANY: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 55. STAAR SURGICAL COMPANY: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 56. ACTAVIS PLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 57. ACTAVIS PLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 58. ACTAVIS PLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 59. COOPERVISION AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 60. COOPERVISION AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 61. COOPERVISION AG: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Diabetic Eye Disease Devices Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved